Palisade Bio PALI
NASDAQ PALI
$1.45 -0.05 (-3.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Non-Current Debt (2013 - 2020)

Updated

Palisade Bio (PALI) reported Non-Current Debt of $94,000 for Q4 2020.

Analysis

Palisade Bio (PALI) Non-Current Debt (2013 - 2020) Analysis & Trends

Dating back to Q1 2013, Palisade Bio's Non-Current Debt record includes 14 quarters.

  • Non-Current Debt has a five-year compound annual growth rate of -51.2% (FY2015 to FY2020).
  • The Q4 2020 figure ranks as the highest quarterly Non-Current Debt in data going back to Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Palisade Bio 260.39 Mn -136.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 94,000.00
Mar 31, 2016 2.55 Mn
Dec 31, 2015 3.38 Mn
Sep 30, 2015 4.63 Mn
Jun 30, 2015 5.81 Mn
Mar 31, 2015 6.95 Mn
Dec 31, 2014 8.06 Mn
Sep 30, 2014 2.61 Mn
Jun 30, 2014 3.42 Mn
Mar 31, 2014 4.19 Mn
Dec 31, 2013 4.93 Mn
Sep 30, 2013 5.66 Mn
Jun 30, 2013 6.36 Mn
Mar 31, 2013 7.04 Mn
API Access

Palisade Bio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PALI&period=max&api_key=YOUR_API_KEY